Azzari, Chiara
Diez-Domingo, Javier
Eisenstein, Evelyn
Faust, Saul N.
Konstantopoulos, Andreas
Marshall, Gary S.
Rodrigues, Fernanda
Schwarz, Tino F.
Weil-Olivier, Catherine http://orcid.org/0000-0001-5271-1945
Funding for this research was provided by:
Pfizer Inc.
Article History
Received: 7 March 2019
Revised: 12 September 2019
Accepted: 21 October 2019
First Online: 18 February 2020
Compliance with ethical standards
:
: All authors received honoraria, paid either to themselves or to their institutions, from Pfizer for participation in and/or travel to the Advancing Adolescent Health Spring Forum. In addition, CA has received honoraria for lecturing and/or as a member of advisory boards from MSD, Pfizer, and Sanofi Pasteur. JD-D has received honoraria from Sanofi Pasteur, Pfizer, and GSK for board membership and lectures, paid both to him and his institution, and has grants or pending grants from MSD awarded to his institution. EE has received honoraria as a past member of an IDMC for HPV vaccine from GSK. FR has been a speaker on industry-sponsored symposia organized by Pfizer and MSD and a member of advisory boards organized by Pfizer and GSK, with honoraria paid to Associação de Saúde Infantil de Coimbra (ASIC), and has an unrestricted research grant from Pfizer awarded to Associação de Saúde Infantil de Coimbra (ASIC). The honorarium for FR’s participation in the Advancing Adolescent Health Spring Forum was paid to Associação de Saúde Infantil de Coimbra (ASIC). SNF’s employers (University and Hospital) have received honoraria for his participation in advisory boards organized by vaccine and antimicrobial agent manufacturers (including Pfizer), and for his participation as a speaker in an industry-sponsored symposium (Pfizer); the University or Hospital has also received grants or pending grants for SNF’s role as a principal investigator for contract commercial clinical trials for multiple pharmaceutical companies, including Pfizer, and as a principal investigator for an investigator-led clinical study funded by Pfizer. AK has no additional disclosures. GSM has been an investigator, on behalf of his institution, on clinical trials funded by GSK, Merck, Novartis, Pfizer, Sanofi Pasteur, and Seqirus, and he has received honoraria from these companies for service on advisory boards. He has also received honoraria from Pfizer and Sanofi for non-branded presentations. TFS has received honoraria from Pfizer, Sanofi Pasteur, and Biogen for lecturing and from GSK and Pfizer as a member of advisory boards, and has received honoraria from GSK and Pfizer for conducting clinical vaccine trials. CWO has received honoraria for lecturing and/or as a member of advisory boards from AstraZeneca, Baxter, GSK, Medimmune, MSD, Pfizer, Sanofi Pasteur, and Seqirus.